Skip to main content

Women's Hearts: Biomarkers for Precision-Based Care and Biological Discovery

Tracking # 20-1340186

Price not reported

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Broadcasted Interactive Event
Dates Contact provider

Course overview

Women's cardiovascular health is shaped by unique biological factors that are often underrecognized in clinical practice. This session explores sex-specific differences in cardiac biomarkers--including troponin and natriuretic peptides--highlighting their clinical relevance and diagnostic implications in female patients. Participants will gain practical insights into how biomarker data can guide diagnosis and inform care strategies throughout a woman's lifespan. The session also emphasizes the laboratory's critical role in enabling personalized and preventive cardiovascular care. Join us to discover how biomarker-driven strategies can support holistic, future-focused care for women.

Subject areas

This course counts toward the state boards and subject areas below.

American Board of Clinical Chemistry

Clinical Chemistry Diplomate

1h Category 1

Molecular Diagnostics Diplomate

1h Category 1

Toxicological Chemistry Diplomate

1h Category 1

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

1h General

Clinical Laboratory Supervisor

1h General

Clinical Laboratory Technician

1h General

Clinical Laboratory Technologist

1h General

Public Health Director

1h General

Public Health Supervisor

1h General

Public Health Technologist

1h General

Disclosure statements

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.


The following faculty reported financial relationships:

  • Emily S. Lau, MD, MPH
  • ¿Consulting Fees: SystoleHealth, Inc.
  • Grant and/or Research Support: NIH/NHLBI, American Heart Association, Massachusetts Life Sciences Center, Dongqiao and Chrissy Chen Institute
  • Commitee/Advisory Board: Amissa Health and Roon